UroGen Pharma announces inducement grants under Nasdaq Rule 5635(c)(4)
UroGen Pharma announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.